Qualcomm Incorporated (QCOM - Free Report) has redefined the computing and mobile ecosystem across the globe with the launch of QCA6390 Connectivity system-on-a-chip (SoC) product. This game-changing and arguably the most advanced integrated offering yet from Qualcomm is likely to deliver path-breaking performance in the 5G era and provide it a competitive advantage against rivals.
Built on indigenous technologies, the QCA6390 is designed to meet the growing need for faster connectivity options and data speed. Supporting all the feature suites of both Wi-Fi 6 and Bluetooth 5.1, it offers faster, more secure and robust Wi-Fi experiences and enhanced Bluetooth capabilities. These include ultra-high-definition voice and low-latency gaming over wireless headphones, earbuds and speakers.
The QCA6390 sets a new industry standard with the world's first announced 14nm integrated SoC that boasts extended features and cutting-edge design. It is likely to help users experience seamless transition to super-fast 5G networks, delivering low-power resilient multi-gigabit connectivity with unprecedented range and Qualcomm’s best-in-class security. This, in turn, would further offer the flexibility and scalability needed for broad and fast 5G adoption through accelerated commercialization by OEMs.
Qualcomm has introduced power-packed features in QCA6390 to improve spectral efficiency, capacity and help ensure seamless experiences across congested networks. With data speed approaching 1.8 Gbps, it offers the highest throughput of any comparable smartphone chipset to date. It further enables to double the throughput performance through dual-band simultaneous 2x2 MIMO operations and 8-stream sounding. The 14nm process node combined with advanced power-management architecture has also enhanced power efficiency by up to 50% compared to previous generation solutions.
Qualcomm is one of the largest manufacturers of wireless chipset based on baseband technology. With such innovative products, the company aims to retain its leadership in 5G, chipset market and mobile connectivity. The company continues to execute its strategic objectives, including driving the global transition to 5G, protecting its intellectual property rights and expanding into new industries and product categories for future growth. Qualcomm’s Snapdragon 855 is also gaining significant momentum with more than 100 design wins in development. It also introduced the custom-built Snapdragon 8cx Compute Platform, which represents the largest generational performance increase ever for Snapdragon product. Qualcomm is on track to deliver $1 billion in operating cost savings from its $7.4 billion baseline, and expects additional savings post licensing resolution as litigation costs fall.
Qualcomm currently carries a Zacks Rank #3 (Hold). Better-ranked stocks in the industry include Comtech Telecommunications Corp. (CMTL - Free Report) , Harris Corporation (HRS - Free Report) and Motorola Solutions, Inc. (MSI - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Comtech has a long-term earnings growth expectation of 5%. It delivered average positive earnings surprise of 252.3% in the trailing four quarters, beating estimates in each.
Harris has a long-term earnings growth expectation of 8%. It delivered average positive earnings surprise of 2.9% in the trailing four quarters, beating estimates in each.
Motorola has a long-term earnings growth expectation of 8%. It delivered average positive earnings surprise of 13.2% in the trailing four quarters, beating estimates on each occasion.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>